Core Entrustable Professional Activities in Clinical Pharmacology for Entering Residency: Biologics

Vera S Donnenberg; Maja Mandic; John C Rhee; Timothy F Burns; Bernd Meibohm; Joan M Korth-Bradley

doi:10.1002/jcph.938

Core Entrustable Professional Activities in Clinical Pharmacology for Entering Residency: Biologics

J Clin Pharmacol. 2017 Aug;57(8):947-955. doi: 10.1002/jcph.938. Epub 2017 Jun 14.

Authors

Vera S Donnenberg^{1

2

3

4}, Maja Mandic⁵, John C Rhee⁵, Timothy F Burns^{2

5}, Bernd Meibohm^{4

6}, Joan M Korth-Bradley^{4

7}

Affiliations

¹ Department of Cardiothoracic Surgery, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
² University of Pittsburgh Cancer Institute, Pittsburgh, PA, USA.
³ McGowan Institute of Regenerative Medicine, Pittsburgh, PA, USA.
⁴ The American College of Clinical Pharmacology, Rockville, MD, USA.
⁵ The UPMC Shadyside, Pittsburgh, PA, USA.
⁶ The University of Tennessee Health Science Center, Memphis, TN, USA.
⁷ Pfizer Inc., Collegeville, PA, USA.

PMID: 28614591
DOI: 10.1002/jcph.938

Abstract

Biologicals are a rapidly expanding class of medications used in the treatment of many different conditions. This article reviews the common characteristics of this class and the requirements for safe and effective use in patients. Several vignettes are included to illustrate common challenges.

Keywords: GME; UME; antibodies; biologics; entrustable professional activities (EPAs) in clinical pharmacology; medical education; prescribing practices; proteins.

Publication types

Review

MeSH terms

Antibodies, Monoclonal / therapeutic use
Biological Products / therapeutic use*
Clinical Competence
Humans
Internship and Residency
Pharmacology, Clinical

Substances

Antibodies, Monoclonal
Biological Products